Monday, 16 December 2019

Drug Discovery News

  • FDA warns Genentech researcher for trial data validity

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jul, 2013

    Singapore: The US FDA has given a warning to Dr Bernard Doft, a phase III investigator of Genentech's Lucentis macular degeneration treatment, for failing to follow the protocol and maintai...Read more

  • Pall to acquire Atmi for $185 million

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Feb, 2014

    Singapore: Pall Corporation, a developer of filtration, separation and purification technology, has decided to acquire Atmi LifeSciences, a technology company in the field of single-use bio...Read more

  • Now 9-yr-old girls can use Cervarix for cancer

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 07 May, 2013

    Singapore: Cervarix has now been approved for use in females aged nine-to-25 years to prevent persistent infection, premalignant cervical lesions and cervical cancer caused by Human Papillo...Read more

  • Novotech to support drug development in Korea

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jul, 2014

    Singapore: Australian clinical research organization, Novotech, has partnered with Korea Drug Development Fund (KDDF) to promote development of Korean biotechnology sector in the Asia Pacif...Read more

  • Xiangxue Pharma acquires rights for Kinex KX02

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 22 May, 2012

    Singapore: Kinex Pharmaceuticals executed a license agreement with Xiangxue Pharmaceuticals granting Xiangxue Pharmaceuticals exclusive rights to Kinex's KX02 for all oncology indications i...Read more

  • Alchemia appoints new chairman

    Drug Discovery |  Influencers | By BioSpectrum Bureau  | 0 Comment | 11 Feb, 2014

    Singapore: Alchemia, Australia based drug discovery and development company, has appointed Mr. Santo J. Costa as non-executive Chairman of the Board of Directors, effective as of 1 March 20...Read more

  • Bionomics, Merck Serono end agreement

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jun, 2012

    Singapore: Australian company Bionomics and Merck Serono, a division of Merck, Darmstadt Germany, have mutually ended their agreement to jointly develop new treatments for MS and other aut...Read more

  • Chinese, Hong Kong scientists map H7N9 risk infection

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 May, 2013

    Singapore: A map of avian influenza (H7N9), comprising of bird migration patterns and estimations of poultry production and consumption, which can be used to determine future risk and advis...Read more

  • AstraZeneca, Alchemia sign $240 mn drug deal

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 23 Apr, 2013

    Singapore: Alchemia signed a multi-target, drug discovery collaboration with AstraZeneca. The collaboration includes the use of the proprietary Diversity Scanning Array (DSA) and associated...Read more

  • Takeda gets Japanese NDA approval for obesity drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 23 Sep, 2013

    Singapore: Japan-based Takeda Pharmaceutical and Amsterdam-based Norgine has received Japanese Ministry of Health, Labour and Welfare approval for the new drug application (NDA) of Oblean ...Read more

  • Lilly reveals phase III trial data on back pain

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Aug, 2012

    Singapore: Eli Lilly and Company published data from a phase III trial comparing the effects of FORTEO (teriparatide, rDNA origin injection) and risedronate on back pain in postmenopausal w...Read more

  • Takeda's diabetes drug gets Chinese FDA nod

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 01 Aug, 2013

    Singapore: Japanese major Takeda Pharmaceutical has said that the China's State Food and Drug Administration (SFDA) has issued them an Import Drug License (IDL) for Nesina (alopliptin) for ...Read more

  • Aveo, Astellas report cancer trial results

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Feb, 2013

    Singapore: Aveo Oncology and Astellas Pharma announced overall survival (OS) for tivozanib, an investigational agent, from the phase III TIVO-1 (Tivozanib versus sorafenib in first line adv...Read more

  • UK, Belgium nod for Bone Therapeutics' therapy

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2013

    Singapore: Europe-based Bone Therapeutics, a biopharmaceutical company focused on innovative cell therapy products for the treatment of bone diseases, received clearance from authorities in...Read more

  • Japan, Singapore to bring innovation in drug, device, technology

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 29 Nov, 2013

    Singapore: Japan's Kanagawa Prefecture's Global Collaboration Center for Life Innovation (GCC) and the Agency for Science, Technology and Research (A*Star), the National University of Singa...Read more

  • Cancer claimed 8.2 mn lives in 2012: UN

    Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Feb, 2014

    Singapore: Cancer is the biggest cause of mortality worldwide as the killer disease claimed an estimated 8.2 million lives in 2012 and the number of cases is set to rise by 75 percent in co...Read more

  • Protagonist, Ironwood expand peptide R&D deal

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 21 Dec, 2012

    Singapore: US-based Protagonist Therapeutics and Australia-based Ironwood Pharmaceuticals expanded their research collaboration leveraging Protagonist's proprietary disulfide‐rich pep...Read more

  • UK recommends BMS's Yervoy for skin cancer

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 02 Nov, 2012

    Singapore: National Institute of Health and Clinical Excellence (NICE) has decided to recommend Bristol-Myers Squibb's YERVOY (ipilimumab), which is approved in the European Union for the t...Read more



Survey Box

Is APAC region emerging as a leader in assistive technologies?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls